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Background
In 2004 seven Italian centers reported survival data for
patients with thalassemia major (TM) and showed that
heart disease due to iron overload was the most com-
mon cause of death (Borgna et al Haematologica 2004).
In the same years the accurate and noninvasive assess-
ment of cardiac siderosis was made possible in Italy by
the introduction of the T2* cardiovascular magnetic
resonance (CMR).
We aimed to evaluate if the deployment of T2* CMR
had an impact on the mortality rate.
Methods
Four centers contributed to the present study, updating
the data of the enrolled patients until August 31, 2010.
For the patients who died, the date of the death repre-
sented the end of the study. 577 patients (264 females
and 313 males) were included.
Results
One-hundred and fifty-nine (27.6%) patients died, 124 of
whom (77.9%) died before the year 2000. MRI was not
performed in 406 patients (70.4%) and no patient had
been scanned before his/her death. Among the survi-
vors, MRI was not performed in the 59% of the cases
(P < 0.0001). The absence of an MRI scan was a signifi-
cant univariate prognosticator for death (HR = 43.25,
95%CI = 11.32-165.33, P<0.0001).
The study was restricted to the patients dead after
2004 (19/159=12%) or followed until August 2010 (N =
357). In this subgroup of 376 patients, MRI was not per-
formed in the 52.4% of the survivors and in all dead
patients (P<0.0001). The absence of a MRI exam was
reconfirmed as a strong predictive factor for death
(HR=49.37, 95%CI = 1.08-2263.24, P = 0.046). The
Kaplan-Meier curve is showed in Figure 1. The log-
rank test revealed a significant difference in the curves
(P < 0.0001).
Conclusions
Our data suggests that the use of T2* CMR, that enables
individually tailored chelation regimes reducing the like-
lihood of developing decompensated cardiac failure,
allowed the reduction of cardiac mortality in chronically
transfused TM patients.
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Figure 1 Kaplan-Meier survival curve.
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